We are Allarta – a regenerative medicine company with platform technology for allogeneic cell therapies.
Built on 30+ years of foundational expertise, Allarta’s proprietary platform is designed to overcome immune rejection, prevent cell escape and safely deliver cell and stem cell therapies.
Our lead product is a cell therapy focused on type 1 diabetes (T1D) as a first indication.
Allarta Life Science was co-founded in 2019 by Dr. Harald Stover, one of the world’s leading researchers in polymers and polymer hydrogels, and Maria Antonakos, a veteran leader in STEM.
Harald Stover, PhD
Founder and CEO
Maria Antonakos, MBA
Founder and COO